Patent assignee · US · COMPANY

Idenix Pharmaceuticals LLC

99Patents
65Active
99Granted
52Portfolio score

Filing activity: Feb 26, 2001 → Jun 13, 2019 · 20 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7105493B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 179 Expired
US6914054B2 Methods and compositions for treating hepatitis C virus Physics 168 Expired
US7608597B2 Methods and compositions for treating hepatitis C virus Physics 153 Expired
US6812219B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 147 Expired
US7608600B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 144 Expired
US7148206B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 126 Expired
US7163929B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 123 Expired
US7169766B2 Methods and compositions for treating hepatitis C virus Physics 101 Expired
US7365057B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections Chemistry; Metallurgy 95 Expired
US7635689B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 93 Expired
US7157441B2 Methods and compositions for treating hepatitis C virus Physics 93 Expired
US6787526B1 Methods of treating hepatitis delta virus infection with &bgr;-L-2′-deoxy-nucleosides Chemistry; Metallurgy 81 Expired
US7951789B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 69 Active
US7625875B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 67 Expired
US7547704B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 64 Expired
US7456155B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 64 Expired
US7192936B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 61 Expired
US6566344B1 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 61 Expired
US7138376B2 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Chemistry; Metallurgy 61 Expired
US7902202B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 60 Active
US7384924B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 59 Expired
US7582618B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 58 Active
US9211300B2 4′-fluoro nucleosides for the treatment of HCV Chemistry; Metallurgy 55 Active
US7662798B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 55 Expired
US7824851B2 2′-branched nucleosides and Flaviviridae mutation Emerging Cross-Sectional Technologies 54 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.